|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Short-term marketable securities | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Inventories | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Prepaid expenses | |||||||||||||
| Other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Long-term marketable securities | |||||||||||||
| Restricted cash | |||||||||||||
| Property and equipment, net | |||||||||||||
| Right-of-use assets | |||||||||||||
| Intangible assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Deferred income taxes | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders' Equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Deferred revenue, current | |||||||||||||
| Operating lease liabilities, current | |||||||||||||
| Notes payable, current | |||||||||||||
| Other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Operating lease liabilities, non-current | |||||||||||||
| Convertible senior notes | |||||||||||||
| Deferred income taxes | |||||||||||||
| Deferred revenue, non-current | |||||||||||||
| Other non-current liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Redeemable convertible preferred stock | |||||||||||||
| Stockholders' Equity: | |||||||||||||
| Common stock, $0.001 par value, 1,000,000 and 1,000,000 shares authorized as of December 31, 2022 and December 31, 2021, respectively; 206,031 and 191,722 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||
| Noncontrolling interest | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||
Loading...
